IE
LVACU

Israel Englander’s LAVA Medtech Acquisition Corp. Unit LVACU Stock Holding History

Israel Englander’s Portfolio LVACU Stock Details LVACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-155,000
Closed -$1.56M – 7933
2022
Q1 		$1.56M Sell
155,000
-37,500
-19% -$379K ﹤0.01% 4093
2021
Q4 		$1.94M Buy
+192,500
New +$1.95M ﹤0.01% 3810

Other funds holding LVACU

CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Israel Englander's LVACU Position: Q2 2022 in Review

Israel Englander sold out of LAVA Medtech Acquisition Corp. Unit (LVACU) in Q2 2022, closing a stake of 155,000 shares — an estimated $1.56M sold.

Israel Englander first reported a position in LVACU in Q4 2021 and held it in 2 quarters. The position peaked at $1.94M in Q4 2021. 14 funds tracked by Wall St. Rank hold LVACU as of Q2 2022.

  • Israel Englander reported no remaining LAVA Medtech Acquisition Corp. Unit position as of Q2 2022 after selling out during the quarter.
  • Israel Englander sold 155,000 LAVA Medtech Acquisition Corp. Unit shares in Q2 2022, an estimated $1.56M.
  • Israel Englander first reported a position in LAVA Medtech Acquisition Corp. Unit in Q4 2021 and held it in 2 quarters.
  • Israel Englander's LAVA Medtech Acquisition Corp. Unit position peaked at $1.94M in Q4 2021.
  • 14 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Unit as of Q2 2022.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.